James M Fleckenstein1,2, F Matthew Kuhlmann3. 1. Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis, MO, 63110, USA. jflecken@wustl.edu. 2. Medicine Service, Veterans Affairs Medical Center, Saint Louis, MO, USA. jflecken@wustl.edu. 3. Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis, MO, 63110, USA.
Abstract
PURPOSE OF REVIEW: Review recent developments pertaining to the epidemiology, molecular pathogenesis, and sequelae of enterotoxigenic Escherichia coli (ETEC) infections in addition to discussion of challenges for vaccinology. RECENT FINDINGS: ETEC are a major cause of diarrheal illness in resource poor areas of the world where they contribute to unacceptable morbidity and continued mortality particularly among young children; yet, precise epidemiologic estimates of their contribution to death and chronic disease have been difficult to obtain. Although most pathogenesis studies, and consequently vaccine development have focused intensively on canonical antigens, more recently identified molecules unique to the ETEC pathovar may inform our understanding of ETEC virulence, and the approach to broadly protective vaccines. ETEC undeniably continue to have a substantial impact on global health; however, further studies are needed to clarify the true impact of these infections, particularly in regions where access to care may be limited. Likewise, our present understanding of the relationship of ETEC infection to non-diarrheal sequelae is presently limited, and additional effort will be required to achieve a mechanistic understanding of these diseases and to fulfill Koch's postulates on a molecular level. Precise elucidation of the role played by novel virulence factors, the global burden of acute illness, and the contribution of these pathogens and/or their toxins to non-diarrheal morbidity remain important imperatives.
PURPOSE OF REVIEW: Review recent developments pertaining to the epidemiology, molecular pathogenesis, and sequelae of enterotoxigenic Escherichia coli (ETEC) infections in addition to discussion of challenges for vaccinology. RECENT FINDINGS: ETEC are a major cause of diarrheal illness in resource poor areas of the world where they contribute to unacceptable morbidity and continued mortality particularly among young children; yet, precise epidemiologic estimates of their contribution to death and chronic disease have been difficult to obtain. Although most pathogenesis studies, and consequently vaccine development have focused intensively on canonical antigens, more recently identified molecules unique to the ETEC pathovar may inform our understanding of ETEC virulence, and the approach to broadly protective vaccines. ETEC undeniably continue to have a substantial impact on global health; however, further studies are needed to clarify the true impact of these infections, particularly in regions where access to care may be limited. Likewise, our present understanding of the relationship of ETEC infection to non-diarrheal sequelae is presently limited, and additional effort will be required to achieve a mechanistic understanding of these diseases and to fulfill Koch's postulates on a molecular level. Precise elucidation of the role played by novel virulence factors, the global burden of acute illness, and the contribution of these pathogens and/or their toxins to non-diarrheal morbidity remain important imperatives.
Authors: J Taranger; B Trollfors; E Bergfors; N Knutsson; T Lagergård; R Schneerson; J B Robbins Journal: Pediatrics Date: 2001-12 Impact factor: 7.124
Authors: Mark D Niehaus; Sean R Moore; Peter D Patrick; Lori L Derr; Breyette Lorntz; Aldo A Lima; Richard L Guerrant Journal: Am J Trop Med Hyg Date: 2002-05 Impact factor: 2.345
Authors: Timothy S Naimi; Julie H Wicklund; Sonja J Olsen; Gerard Krause; Joy G Wells; Joanne M Bartkus; David J Boxrud; Maureen Sullivan; Heidi Kassenborg; John M Besser; Eric D Mintz; Michael T Osterholm; Craig W Hedberg Journal: J Food Prot Date: 2003-04 Impact factor: 2.077
Authors: Marija Tauschek; Rebecca J Gorrell; Richard A Strugnell; Roy M Robins-Browne Journal: Proc Natl Acad Sci U S A Date: 2002-05-14 Impact factor: 11.205
Authors: Alaullah Sheikh; Tamding Wangdi; Tim J Vickers; Bailey Aaron; Margot Palmer; Mark J Miller; Seonyoung Kim; Cassandra Herring; Rita Simoes; Jennifer A Crainic; Jeffrey C Gildersleeve; Sjoerd van der Post; Gunnar C Hansson; James M Fleckenstein Journal: Infect Immun Date: 2021-11-22 Impact factor: 3.609
Authors: F M Kuhlmann; R O Laine; S Afrin; R Nakajima; M Akhtar; T Vickers; K Parker; N N Nizam; V Grigura; C W Goss; P L Felgner; D A Rasko; F Qadri; J M Fleckenstein Journal: Infect Immun Date: 2021-04-16 Impact factor: 3.441
Authors: Eric Cox; Meryem Aloulou; James M Fleckenstein; Christina Schäffer; Åsa Sjöling; Stephanie Schüller; Kurt Hanevik; Bert Devriendt; Weiping Zhang; Ann-Mari Svennerholm; Edward G Dudley Journal: Appl Environ Microbiol Date: 2020-11-24 Impact factor: 4.792
Authors: F Matthew Kuhlmann; John Martin; Tracy H Hazen; Tim J Vickers; Madeline Pashos; Pablo C Okhuysen; Oscar G Gómez-Duarte; Elizabeth Cebelinski; Dave Boxrud; Felipe Del Canto; Roberto Vidal; Firdausi Qadri; Makedonka Mitreva; David A Rasko; James M Fleckenstein Journal: PLoS Negl Trop Dis Date: 2019-11-22